# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019459
Filing Date
2024-05-15
Accepted
2024-05-15 07:35:44
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 954533
2 |  | ex31-1.htm | EX-31.1 | 16056
3 |  | ex31-2.htm | EX-31.2 | 15974
4 |  | ex32.htm | EX-32 | 12534
| Complete submission text file | 0001493152-24-019459.txt |  | 5812485

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | abeo-20240331.xsd | EX-101.SCH | 44644
6 | XBRL CALCULATION FILE | abeo-20240331_cal.xml | EX-101.CAL | 65441
7 | XBRL DEFINITION FILE | abeo-20240331_def.xml | EX-101.DEF | 194168
8 | XBRL LABEL FILE | abeo-20240331_lab.xml | EX-101.LAB | 383739
9 | XBRL PRESENTATION FILE | abeo-20240331_pre.xml | EX-101.PRE | 316371
79 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 878386

Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 24947169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)